Immune to Cancer: The CRI Blog
-
AACR 2022 Recap: T Cells Still On Top, But Make Room for Myeloid Cells
At the 2022 AACR annual meeting, CRI scientists highlighted a wide scope of cancer immunology advances, and…
-
Head and Neck Cancer Awareness Month: 2022 Immunotherapy Research Updates
This April for Head and Neck Cancer Awareness Month, discover the new research, new treatments, and progress…
-
Esophageal Cancer Awareness Month: 2022 Immunotherapy Research Updates
This April for Esophageal Cancer Awareness Month, discover the new research, new treatments, and progress for a…
-
Ira Mellman Receives 2022 AACR-CRI Lloyd J. Old Award in Cancer Immunology
Dr. Ira Mellman, a longtime member of the CRI Scientific Advisory Council, received CRI’s highest scientific career…
-
AACR 2022 Preview: Decoding Cancer Complexity, Integrating Science, and Transforming Patient Outcomes
During AACR’s upcoming 2022 annual meeting, CRI scientists will share the latest advances in cancer immunotherapy.
-
FDA Immunotherapy Approvals in 2022
As drug development in cancer immunotherapy has accelerated, the U.S. Food and Drug Administration has made several…
-
Mining the Mysteries of Myeloid Cells with CRI Lloyd J. Old STAR Malay Haldar
CRI Lloyd J. Old STAR Malay Haldar is exploring the role of dendritic cells and macrophages in…
-
FDA Approves New LAG-3 Checkpoint Inhibitor Immunotherapy Combination
Patients with unresectable or metastatic melanoma can now be treated with dual checkpoint blockade targeting the PD-1…
-
Neutrophils and Inflammation in Colorectal Cancer with CRI Lloyd J. Old STAR Ivan Zanoni
CRI Lloyd J. Old STAR Ivan Zanoni is exploring the multifaceted roles of neutrophils in colorectal cancer.
Join CRI in Shaping the Future of Immunotherapy
Support the pioneering work of CRI in advancing immunotherapy.